Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/elamCfbwocfChAyxYYCO

Emergo Group - International medical device QA/RA consulting. Offices worldwide. Request a Proposal.
February 20, 2013
BIO has teamed up with FedEx to offer member companies discounts of up to 35% off select FedEx Express, FedEx Ground and FedEx Home Delivery services through the BIO Business Solutions cost-savings program. Learn more.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at bio@smartbrief.com.

  Today's Top Story 
  • Breaking down the list of biopharma's most influential
    Leaders of big drugmakers, including Sanofi, Roche and GlaxoSmithKline, make up the biggest contingent in the FiercePharma list of the 25 most influential people in biopharma. Also present on the list are executives at small biotechs, philanthropist Bill Gates, investor Dietmar Hopp and researchers Craig Venter and Bob Langer. Forbes (2/19) LinkedInFacebookTwitterEmail this Story
Gene Location Affects Properties, Impacts on Regulatory Pathways
Boston – Location, location, location: The idea that one gene equals one protein is long discredited and research into mechanisms including post-translational modification proteins and the baroque complexities of epigenetic control is advancing understanding of how one gene can generate multiple proteins. Find out the details.

  Health Care & Policy 
  • Exact advances PMA application for colorectal cancer test
    Exact Sciences has submitted to the FDA the second module of its premarket approval application for Cologuard, a DNA test that uses stool samples to screen for colorectal cancer. The Madison, Wis.-based company plans to submit a third and final module using results from its DeeP-C pivotal clinical trial, which it said earlier are likely to be available by March. GenomeWeb Daily News (free registration) (2/18) LinkedInFacebookTwitterEmail this Story
  • Firms ally to develop plant-based drugs
    Caliber Biotherapeutics and iBio agreed to jointly develop and produce recombinant plant-based biopharmaceuticals using Caliber's plant-based production expertise and the iBioLaunch platform. The partners will initially work on a monoclonal antibody for cancer. iBio will get license and milestone fees and sales royalties on products arising from the collaboration. Genetic Engineering & Biotechnology News (2/19) LinkedInFacebookTwitterEmail this Story
  • Gilead's hep C drug sofosbuvir hits primary goal in 4th Phase III trial
    Hepatitis C patients who took Gilead Sciences' sofosbuvir had cure rates of 50% at 12 weeks and 73% at 16 weeks for genotypes 2 and 3, compared with a 25% historic cure rate with other drugs, data from a late-stage trial showed. "With positive results from all four Phase 3 trials now in hand, Gilead is on track to meet its goal of filing regulatory applications in the United States and Europe in the second quarter," Gilead Chief Scientific Officer Norbert Bischofberger said. Yahoo/Reuters (2/19) LinkedInFacebookTwitterEmail this Story
  • Obama administration to unveil 10-year brain-mapping project
    The Obama administration is looking to unveil next month a 10-year project to map the active human brain, called Brain Activity Map. Scientists say the project may pave the way for the development of technologies that will help improve understanding of neurological conditions such as Alzheimer's and Parkinson's disease. The project, which may be worth $3 billion over 10 years, may also allow for the creation of national brain "observatories," akin to astronomical observatories. The New York Times (tiered subscription model) (2/17) LinkedInFacebookTwitterEmail this Story
Get Creative: 10 Ways to Think Outside the Box
No matter your business, smart solutions come from out-of-the-box thinking. We all know creativity is king, but are you doing all you can to inspire and encourage creativity in your staff? Read the article and learn 10 ways to inspire creativity at your office.

  Company & Financial News 
 
  • Isis gets $7.5 million from GSK for antisense drug trial
    GlaxoSmithKline is paying Isis Pharmaceuticals a $7.5 milestone fee for launching a Phase II/III trial of ISIS-TTRRx, an experimental antisense drug for transthyretin amyloidosis. The partners plan to use the results of the trial to support an application for marketing approval in patients with familial amyloid polyneuropathy. RTT News (2/19) LinkedInFacebookTwitterEmail this Story
Clinical Trial Data Transparency Forum: Expert insights
Hear industry and academic thought leaders - from Duke Clinical Research Institute, GlaxoSmithKline, Eli Lilly and more - share valuable insight on their clinical trial data transparency and sharing initiatives. This video covers a number of key perspectives and trends.

  Food & Agriculture 
  • Report: Biotech crop acreage grows to new high
    The total global planted area of biotech crops reached 170.3 million hectares in 2012, 10.3 million hectares more than in the previous year, according to a report from the International Service for the Acquisition of Agri-Biotech Applications. Growers who used biotech seeds numbered 17.3 million, an increase of 600,000. The U.S. remains the top grower of biotech crops with 69.5 million hectares of planted area, followed by Argentina and Canada. Reuters (2/19) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • Startup, university to research heat-tolerant fungus for biofuel
    Sustainable Bioproducts is partnering with Montana State University to study the biofuel potential of heat-tolerant fungus from Yellowstone National Park's hot springs that converts the cellulose in algae into oil. "The most important part of our research now is to test the technology further and investigate the feasibility of using this organism to produce biofuels and other products," said company founder Mark Kozubal. The National Science Foundation has awarded an initial grant of $150,000 to the venture. Biofuels-News.com (U.K.) (2/18) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or mharold@smartbrief.com. 

  News from BIO 
  • Are you taking full advantage of your membership?
    BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

  SmartQuote 
We must travel in the direction of our fear."
--John Berryman,
American poet and scholar


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information